CG Oncology CGON
NASDAQ CGON
$73.39 +0.75 (+1.03%)
As of: Nov 11, 2026 · 1:35 PM EST

CG Oncology (CGON) Depreciation and Depletion (2024 - 2026)

Updated

CG Oncology's Depreciation and Depletion came in at $900,000 for Q2 2026, up 12.5% from the prior quarter.

Analysis

CG Oncology (CGON) Depreciation and Depletion (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, CG Oncology reported Depreciation and Depletion of $3 million; for FY2025, it came in at $1.4 million.

  • Going back by year, Depreciation and Depletion was $100,000 in FY2024 (unchanged) and $100,000 in FY2023.
  • Business Quant data shows CGON's Depreciation and Depletion at $800,000 (Q1 2026), $800,000 (Q4 2025) and $500,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 CG Oncology 6.49 Bn 2.66 Bn -1.07 Mn 900,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 900,000.00
Jun 30, 2026 900,000.00
Mar 31, 2026 800,000.00
Dec 31, 2025 1.30 Mn
Sep 30, 2025 100,000.00
Mar 31, 2025 100,000.00
Sep 30, 2024 100,000.00
API Access

CG Oncology Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=CGON&period=max&api_key=YOUR_API_KEY